ArticleTranslational pediatrics2026
Risk factors and construction of prediction model for plastic bronchitis in children with
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Children's health is at serious risk due to the possibility of developing life-threatening plastic bronchitis (PB) from severe Methods: A total of 180 children with SMPP were the subject of a retrospective analysis. Patients were divided into a PB group (60 cases) and a non-PB group (120 cases) based on the results of fiberoptic bronchoscopies. Imaging results, laboratory data, and clinical traits were compared between groups. Candidate predictors of PB were initially screened using univariable analysis and the least absolute shrinkage and selection operator (LASSO) regression. Independent risk factors were subsequently identified through multivariate logistic regression, and a prediction model was constructed. Internal validation was performed on the model, and its discriminatory power, calibration, and clinical value were assessed using receiver operating characteristic (ROC), calibration, and clinical decision curves. Results: Independent risk variables for PB in children with SMPP were history of intensive care unit (ICU) admission [odds ratio (OR): 4.32; 95% confidence interval (CI): 1.41-13.82; P=0.01], fever duration (OR: 1.26; 95% CI: 1.09-1.47; P=0.002), neutrophil percentage (OR: 1.05; 95% CI: 1.01-1.09; P=0.03), and lactate dehydrogenase (OR: 1.01; 95% CI: 1.01-1.01; P<0.001). The predictive model built using these parameters had a sensitivity of 81.7% and a specificity of 85.0%, with an area under the curve (AUC) of 0.871 (95% CI: 0.813-0.929). The model's strong consistency and practical applicability were validated using calibration curves and clinical decision-support analysis. Conclusions: The goal of the study was to develop and validate a nomogram for predicting PB in children with SMPP, thereby facilitating early identification of PB in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.